Study of the Safety and Immunogenicity of Reduced Doses of the US Yellow Fever Vaccine

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 7, 2021

Primary Completion Date

November 2, 2022

Study Completion Date

November 2, 2022

Conditions

Yellow Fever Vaccination Reaction

Interventions

BIOLOGICAL

Yellow Fever Vaccine

Administered subcutaneously once.

Trial Locations (1)

United States Army Medical Research Institute of Infectious Diseases, Frederick

All Listed Sponsors

lead

US Army Medical Research Institute of Infectious Diseases

FED